PLAUR and familial pancreatic carcinoma: The remarkable stromal expression of uPAR also allows targeting this compartment, which offers multiple opportunities to enhance the therapeutic efficacy compared to exclusively targeting the tumor cells, especially in tumors expressing uPAR in both cell types, such as pancreatic cancer, or those lacking a tumor-specific molecular target [11,12,15,52,120,146].